{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:53Z","timestamp":1791994433292,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1279"],"award-info":[{"award-number":["SFB1279"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["D.3830"],"award-info":[{"award-number":["D.3830"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007495","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.yebeh.2025.110321","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:41:32Z","timestamp":1740008492000},"page":"110321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6069-6360","authenticated-orcid":false,"given":"Annemarie","family":"Thaele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Barba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Abu-Rumeileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2025.110321_b0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ane.13616","article-title":"Blood biomarkers in epilepsy","volume":"146","author":"Banote","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2025.110321_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.seizure.2012.10.012","article-title":"Elevated serum S-100B levels in children with temporal lobe epilepsy","volume":"22","author":"Calik","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0015","first-page":"85","article-title":"Serum prolactin levels are elevated also after pseudo-epileptic seizures","volume":"7","author":"Alving","year":"1998","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02191962","article-title":"Serum prolactin concentrations and epilepsy. A study which compares healthy subjects with a group of patients in presurgical evaluation and circadian variations with those related to seizures","volume":"241","author":"Bauer","year":"1992","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2025.110321_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.35.1.31","article-title":"Prolactin changes after seizures classified by EEG monitoring","volume":"35","author":"Laxer","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110321_b0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp.46.6.505","article-title":"Plasma prolactin concentrations following epileptic and pseudoseizures","volume":"46","author":"Collins","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2025.110321_b0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/seiz.1999.0284","article-title":"Serum prolactin levels after seizure and syncopal attacks","volume":"8","author":"Lusi\u0107","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1600-0404.2003.00232.x","article-title":"Serum neuron-specific enolase, prolactin, and creatine kinase after epileptic and psychogenic non-epileptic seizures","volume":"109","author":"Willert","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2025.110321_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders - towards clinical application","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/brain\/awac328","article-title":"The multifaceted role of neurofilament light chain protein in non-primary neurological diseases","volume":"146","author":"Abu-Rumeileh","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110321_b0060","series-title":"Encyclopedia of Neuroscience","first-page":"433","article-title":"Organization and function in neurons","author":"Lobsiger","year":"2009"},{"key":"10.1016\/j.yebeh.2025.110321_b0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021642","article-title":"Type III intermediate filaments desmin, Glial Fibrillary Acidic Protein (GFAP), vimentin, and peripherin","volume":"9","author":"Hol","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.yebeh.2025.110321_b0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0075","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00415-023-11768-1","article-title":"Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis","volume":"270","author":"Abdelhak","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106520","article-title":"Acute symptomatic seizures and epilepsy after mechanical thrombectomy","volume":"104","author":"Eriksson","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110321_b0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2021.08.012","article-title":"Brain injury markers in new-onset seizures in adults: a pilot study","volume":"92","author":"Eriksson","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00415-021-10642-2","article-title":"Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis","volume":"269","author":"Lardeux","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/epd2.20024","article-title":"Serum neurofilament light chain in patients with epilepsy and cognitive impairment","volume":"25","author":"Ueda","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2025.110321_b0100","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/epi.17713","article-title":"Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: high plasma levels are rare but related to seizures","volume":"64","author":"Akel","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109131","article-title":"Neuro-glial degeneration in status epilepticus: exploring the role of serum levels of Neurofilament light chains and S100B as prognostic biomarkers for short-term functional outcome","volume":"140","author":"Giovannini","year":"2023","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110321_b0110","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/epi.17132","article-title":"Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus","volume":"63","author":"Giovannini","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/epi.16742","article-title":"Increased frequency of proinflammatory CD4 T cells and pathological levels of serum neurofilament light chain in adult drug-resistant epilepsy","volume":"62","author":"Ou\u00e9draogo","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/7246373","article-title":"Serum markers of neuronal damage and astrocyte activity in patients with chronic epilepsy: elevated levels of glial fibrillary acidic protein","author":"Mochol","year":"2023","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2025.110321_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2020.12.009","article-title":"Serum biomarkers of cerebral cellular stress after self-limiting tonic clonic seizures: an exploratory study","volume":"85","author":"Nass","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.647428","article-title":"CSF and serum biomarkers of cerebral damage in autoimmune epilepsy","volume":"12","author":"Nass","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0135","first-page":"169","article-title":"Investigation of correlation between resistance to diazepam and expression of inflammatory markers in the peripheral blood of patients with status epilepticus","volume":"52","author":"Mahama","year":"2023","journal-title":"Acta Med Acad"},{"key":"10.1016\/j.yebeh.2025.110321_b0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/jnc.15549","article-title":"Serum neurofilament light chain in adult and pediatric patients with myelin oligodendrocyte glycoprotein antibody-associated disease: correlation with relapses and seizures","volume":"160","author":"Luo","year":"2022","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2025.110321_b0145","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1212\/WNL.0000000000200021","article-title":"Neurofilament light chain levels in anti-NMDAR encephalitis and primary psychiatric psychosis","volume":"98","author":"Guasp","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110321_b0150","doi-asserted-by":"crossref","first-page":"e2204","DOI":"10.1212\/WNL.0000000000207221","article-title":"Predictive value of serum neurofilament light chain levels in anti-NMDA receptor encephalitis","volume":"100","author":"Brenner","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110321_b0155","doi-asserted-by":"crossref","unstructured":"Dobson H, Al Maawali S, Malpas C, Santillo AF, Kang M, Todaro M, Watson R, Yassi N, Blennow K, Zetterberg H, Foster E, Neal A, Velakoulis D, O'Brien TJ, Eratne D, Kwan P. Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders. Epilepsia. 2024 Sep;65(9):2751-2763. doi: 10.1111\/epi.18065. Epub 2024 Jul 20. PMID: 39032019.","DOI":"10.1111\/epi.18065"},{"key":"10.1016\/j.yebeh.2025.110321_b0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2018.07.010","article-title":"Serum GFAP level: a novel adjunctive diagnostic test in differentiate epileptic seizures from psychogenic attacks","volume":"61","author":"Simani","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2025.110321_b0165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.resuscitation.2020.10.027","article-title":"Postanoxic electrographic status epilepticus and serum biomarkers of brain injury","volume":"158","author":"Lybeck","year":"2021","journal-title":"Resuscitation"},{"key":"10.1016\/j.yebeh.2025.110321_b0170","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s00415-022-11547-4","article-title":"Neurofilament light (NfL) as biomarker in serum and CSF in status epilepticus","volume":"270","author":"Margraf","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2025.110321_b0180","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2147\/NDT.S286710","article-title":"D\u0301Alessio L. Updated review on the diagnosis and primary management of psychogenic nonepileptic seizure disorders","volume":"17","author":"Lanzillotti","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2025.110321_b0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1212\/WNL.41.7.965","article-title":"The risk of seizure recurrence following a first unprovoked seizure","volume":"41","author":"Berg","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110321_b0195","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0200","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0205","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jalz.2019.07.009","article-title":"Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin","volume":"15","author":"Mielke","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.yebeh.2025.110321_b0210","doi-asserted-by":"crossref","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group, et al. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. 76 2019 1035 48. Doi: 10.1001\/jamaneurol.2019.1534.","DOI":"10.1001\/jamaneurol.2019.1534"},{"key":"10.1016\/j.yebeh.2025.110321_b0215","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13195-024-01653-y","article-title":"Sex differences in the relationships between 24-h rest-activity patterns and plasma markers of Alzheimer\u2019s disease pathology","volume":"16","author":"Van Egroo","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.yebeh.2025.110321_b0220","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yebeh.2009.02.033","article-title":"Neuropathology of focal epilepsies: a critical review","volume":"15","author":"Bl\u00fcmcke","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110321_b0225","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","article-title":"Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches","volume":"53","author":"Marchi","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10309-019-00301-y","article-title":"Tiermodelle der mesialen Temporallappenepilepsie","volume":"33","author":"Bauer","year":"2020","journal-title":"Z Epileptol"},{"key":"10.1016\/j.yebeh.2025.110321_b0235","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/epi.17669","article-title":"Neurofilament light chain: a possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?","volume":"64","author":"Custers","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110321_b0240","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1007\/s11064-017-2276-y","article-title":"Phase-dependent astroglial alterations in Li-pilocarpine-induced status epilepticus in young rats","volume":"42","author":"Vizuete","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2025.110321_b0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.yebeh.2025.110321_b0250","doi-asserted-by":"crossref","first-page":"26954","DOI":"10.18632\/oncotarget.25485","article-title":"Astroglial role in the pathophysiology of status epilepticus: an overview","volume":"9","author":"Vargas-S\u00e1nchez","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.yebeh.2025.110321_b0255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2018.12.042","article-title":"Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke","volume":"698","author":"Pujol-Calder\u00f3n","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2025.110321_b0260","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1161\/01.STR.31.11.2670","article-title":"Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein","volume":"31","author":"Herrmann","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2025.110321_b0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000172632","article-title":"Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke","volume":"27","author":"Dvorak","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.yebeh.2025.110321_b0270","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yebeh.2015.04.030","article-title":"Cerebrospinal fluid tau proteins in status epilepticus","volume":"49","author":"Monti","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110321_b0275","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.26446","article-title":"Contributors to serum NfL levels in people without neurologic disease","volume":"92","author":"Fitzgerald","year":"2022","journal-title":"Ann Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:26:13Z","timestamp":1774340773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":54,"alternative-id":["S1525505025000605"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110321","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain and glial fibrillary acidic protein as diagnostic and prognostic biomarkers in epileptic seizures and epilepsy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110321"}}